Enzolytics (ENZC) Short Interest Ratio & Short Volume $0.0003 0.00 (-25.00%) As of 03:49 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartShort InterestBuy This Stock Enzolytics Short Interest DataEnzolytics (ENZC) has a short interest of 400 shares. This marks a 100.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 4.58 million shares to cover all short positions.Current Short Interest400 sharesPrevious Short Interest200 sharesChange Vs. Previous Month+100.00%Dollar Volume Sold Short$0.24Short Interest Ratio0.0 Days to CoverLast Record DateAugust 31, 2025Today's Trading Volume10,788,261 sharesAverage Trading Volume4,579,061 sharesToday's Volume Vs. Average236% Short Selling Enzolytics? Sign up to receive the latest short interest report for Enzolytics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENZC Short Interest Over TimeENZC Days to Cover Over TimeENZC Percentage of Float Shorted Over Time Enzolytics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/2025400 shares $0.24 +100.0%N/A0 $0.00 8/15/2025200 shares $0.14 No ChangeN/A0 $0.00 7/31/2025200 shares $0.14 No ChangeN/A0 $0.00 7/15/2025200 shares $0.16 No ChangeN/A0 $0.00 6/30/2025200 shares $0.14 No ChangeN/A0 $0.00 6/15/2025200 shares $0.14 -99.5%N/A0 $0.00 5/31/202538,000 shares $26.60 -11.4%N/A0 $0.00 5/15/202542,900 shares $38.61 -62.6%N/A0 $0.00 4/30/2025114,800 shares $80.36 -19.8%N/A0 $0.00 4/15/2025143,100 shares $114.48 +30.0%N/A0 $0.00 Get the Latest News and Ratings for ENZC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enzolytics and its competitors with MarketBeat's FREE daily newsletter. 3/31/2025110,100 shares $66.06 +6,016.7%N/A0 $0.00 3/15/20251,800 shares $1.26 -99.6%N/A0 $0.00 2/28/2025499,900 shares $399.92 -24.5%N/A0 $0.00 2/15/2025662,300 shares $596.07 +331,050.0%N/A0 $0.00 1/31/2025200 shares $0.18 No ChangeN/A0 $0.00 1/15/2025200 shares $0.18 -99.7%N/A0 $0.00 12/31/202457,300 shares $57.30 +28,550.0%N/A0 $0.00 12/15/2024200 shares $0.25 -99.9%N/A0 $0.00 11/30/2024291,200 shares $262.08 No ChangeN/A0 $0.00 11/15/2024291,200 shares $291.20 No ChangeN/A0 $0.00 10/31/2024291,200 shares $436.80 -76.9%N/A0 $0.00 10/15/20241,260,500 shares $2.14 thousand +115.6%N/A0.1 $0.00 9/30/2024584,700 shares $1.05 thousand +96.2%N/A0 $0.00 9/15/2024298,000 shares $566.20 +2.4%N/A0 $0.00 8/31/2024291,000 shares $785.70 No ChangeN/A0 $0.00 8/15/2024291,000 shares $989.40 No ChangeN/A0 $0.00 7/31/2024291,000 shares $669.30 No ChangeN/A0 $0.00 7/15/2024291,000 shares $494.70 -7.3%N/A0 $0.00 6/30/2024314,000 shares $596.60 +7.9%N/A0 $0.00 6/15/2024291,000 shares $756.60 -19.4%N/A0 $0.00 5/31/2024360,900 shares $1.34 thousand -47.6%N/A0 $0.00 5/15/2024689,300 shares $2.55 thousand -25.9%N/A0 $0.00 4/30/2024929,700 shares $4.59 thousand -33.0%N/A0 $0.00 4/15/20241,387,200 shares $7.71 thousand +16.0%N/A0 $0.01 3/31/20241,196,000 shares $12.71 thousand -16.6%N/A0 $0.01 3/15/20241,434,800 shares $18.65 thousand -31.3%N/A0.2 $0.01 2/29/20242,088,100 shares $37.38 thousand +7.8%N/A0.3 $0.02 2/15/20241,937,200 shares $27.90 thousand +3.1%N/A0.2 $0.01 1/15/20241,576,200 shares $32.63 thousand -3.4%N/A0.1 $0.02 12/31/20231,630,900 shares $28.54 thousand -50.5%N/A0 $0.02 12/15/20233,294,600 shares $49.09 thousand +0.2%N/A0.2 $0.01 11/30/20233,288,300 shares $83.85 thousand -6.6%N/A0.2 $0.03 11/15/20233,519,400 shares $87.28 thousand +11.1%N/A0.4 $0.02 10/31/20233,167,100 shares $94.38 thousand -18.6%N/A0.3 $0.03 10/15/20233,892,300 shares $122.22 thousand +18.5%N/A0.4 $0.03 9/30/20233,285,200 shares $131.08 thousand +1.7%N/A0.2 $0.04 9/15/20233,231,200 shares $125.05 thousand +7.1%N/A0.4 $0.04 8/31/20233,018,500 shares $132.81 thousand +3.9%N/A0.3 $0.04 8/15/20232,906,700 shares $110.45 thousand -1.8%N/A0.2 $0.04 7/31/20232,959,100 shares $126.65 thousand +5.4%N/A0.2 $0.04 7/15/20232,806,800 shares $127.71 thousand +7.2%N/A0.1 $0.05 6/30/20232,618,600 shares $125.69 thousand +0.1%N/A0.2 $0.05 6/15/20232,614,900 shares $136.24 thousand -1.3%N/A0.1 $0.05 5/31/20232,649,300 shares $137.76 thousand -10.9%N/A0.1 $0.05 5/15/20232,973,300 shares $344.90 thousand +20.0%N/A0.1 $0.12 4/30/20232,477,800 shares $153.62 thousand +13.0%N/A0.2 $0.06 4/15/20232,193,300 shares $101.99 thousand -3.6%N/A0.3 $0.05 3/31/20232,274,700 shares $106.91 thousand -1.4%N/A0.5 $0.05 3/15/20232,306,400 shares $104.94 thousand -63.3%N/A0.3 $0.05 2/28/20236,281,400 shares $333.54 thousand +0.9%N/A0.5 $0.05 2/15/20236,225,100 shares $334.91 thousand -2.9%N/A0.8 $0.05 1/31/20236,413,100 shares $290.51 thousand +0.6%N/A0.9 $0.05 1/15/20236,374,200 shares $267.72 thousand -0.1%N/A0.4 $0.04 12/30/20226,379,900 shares $235.42 thousand -0.2%N/A0.3 $0.04 12/15/20226,395,500 shares $254.54 thousand +0.3%N/A1 $0.04 11/30/20226,373,700 shares $293.99 thousand -1.5%N/A0.9 $0.05 11/15/20226,473,700 shares $271.90 thousand -0.8%N/A0.6 $0.04 10/31/20226,527,600 shares $315.94 thousand -3.2%N/A0.4 $0.05 10/15/20226,742,200 shares $330.37 thousand +3.0%N/A0.6 $0.05 9/30/20226,545,400 shares $192.11 thousand +0.5%N/A0.4 $0.03 9/15/20226,511,600 shares $252.65 thousand -0.8%N/A0.6 $0.04 8/31/20226,563,200 shares $315.03 thousand +0.6%N/A0.5 $0.05 8/15/20226,526,200 shares $374.60 thousand +0.3%N/A0.9 $0.06 7/31/20226,508,200 shares $395.76 thousand -0.3%N/A0.5 $0.06 7/15/20226,527,300 shares $417.75 thousand -1.2%N/A0.8 $0.06 6/30/20226,608,800 shares $436.18 thousand +15.3%N/A0.7 $0.07 6/15/20225,731,900 shares $343.91 thousand +50.5%N/A0.4 $0.06 5/31/20223,807,600 shares $232.26 thousand +0.1%N/A0.2 $0.06 5/15/20223,802,100 shares $280.21 thousand +0.6%N/A0.2 $0.07 4/30/20223,778,000 shares $343.61 thousand +0.9%N/A0.1 $0.09 4/15/20223,743,600 shares $253.07 thousand -0.1%N/A0.3 $0.07 3/31/20223,746,300 shares $293.71 thousand +0.5%N/A0.3 $0.08 3/15/20223,728,100 shares $293.77 thousand +0.6%N/A0.3 $0.08 2/28/20223,706,300 shares $333.57 thousand -10.6%N/A0.2 $0.09 2/15/20224,147,000 shares $371.57 thousand +14.8%N/A0.3 $0.09 1/31/20223,612,400 shares $334.15 thousand -6.8%N/A0.2 $0.09 1/15/20223,876,400 shares $405.86 thousand +59.2%N/A0.1 $0.10 12/31/20212,434,400 shares $167.97 thousand -65.2%N/A0.1 $0.07 12/15/20217,003,700 shares $549.79 thousand +0.5%N/A0.2 $0.08 11/30/20216,969,500 shares $791.74 thousand +0.0%N/A0.3 $0.11 11/15/20216,967,900 shares $903.04 thousand +3.0%N/A0.4 $0.13 10/29/20216,768,000 shares $856.83 thousand +7.1%N/A0.3 $0.13 10/15/20216,321,700 shares $1.02 million -4.5%N/A0.2 $0.16 9/30/20216,616,400 shares $1.23 million +2.4%N/A0.2 $0.19 9/15/20216,460,700 shares $966.00 thousand -0.9%N/A0.3 $0.15 8/31/20216,517,100 shares $916.30 thousand +1.8%N/A0.2 $0.14 8/13/20216,401,900 shares $992.29 thousand -4.0%N/A0.3 $0.16 7/30/20216,668,900 shares $1.20 million +3.5%N/A0.2 $0.18 7/15/20216,444,800 shares $1.09 million +4.1%N/A0.2 $0.17 6/30/20216,192,700 shares $1.20 million +1.9%N/A0.1 $0.19 6/15/20216,074,800 shares $1.49 million -0.6%N/A0.1 $0.25 5/28/20216,100,100 shares $719.81 thousand +67.8%N/A0.2 $0.12 5/14/20213,635,100 shares $388.96 thousand +56.7%N/A0.1 $0.11 4/30/20212,319,900 shares $283.03 thousand -11.5%N/A0 $0.12 4/15/20212,622,200 shares $587.37 thousand +42.2%N/A0 $0.22 3/31/20211,844,700 shares $396.61 thousand -8.0%N/A0 $0.22 3/15/20212,005,500 shares $721.38 thousand -39.9%N/A0 $0.36 2/26/20213,339,000 shares $2.17 million +49.3%N/A0.1 $0.65 2/12/20212,236,300 shares $1.60 million +3,973.4%N/A0 $0.72 1/29/202154,900 shares $10.05 thousand -80.9%N/A0 $0.18 1/15/202157,600 shares $7.66 thousand -98.1%N/A0 $0.13 12/31/2020500 shares $38.43 -99.1%N/A0 $0.08 12/15/202057,600 shares $5.35 thousand -98.1%N/A0 $0.09 11/30/20202,968,400 shares $149.01 thousand No ChangeN/A0 $0.05 ENZC Short Interest - Frequently Asked Questions What is Enzolytics' current short interest? Short interest is the volume of Enzolytics shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 400 shares of ENZC short. Learn More on Enzolytics' current short interest. Is Enzolytics' short interest increasing or decreasing? Enzolytics saw a increase in short interest in August. As of August 31st, there was short interest totaling 400 shares, an increase of 100.0% from the previous total of 200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Enzolytics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "entertainment" compare to Enzolytics: Eros Media World Plc (0.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks. What does it mean to sell short Enzolytics stock? Short selling ENZC is an investing strategy that aims to generate trading profit from Enzolytics as its price is falling. ENZC shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enzolytics? A short squeeze for Enzolytics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENZC, which in turn drives the price of the stock up even further. How often is Enzolytics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENZC, twice per month. The most recent reporting period available is August, 31 2025. More Short Interest Resources from MarketBeat Related Companies BLIBQ Short Squeeze BLIAQ Short Squeeze BRVO Short Squeeze CGLD Short Squeeze CRTDW Short Squeeze CURIW Short Squeeze GMVHY Short Squeeze GMVHF Short Squeeze EMWPF Short Squeeze GMBLZ Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ENZC) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzolytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzolytics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENZC Stock Alerts